Number of items: 7.
2023
Rattigan, K. M. et al.
(2023)
Pyruvate anaplerosis is a targetable vulnerability in persistent leukaemic stem cells.
Nature Communications, 14,
4634.
(doi: 10.1038/s41467-023-40222-z)
(PMID:37591854)
(PMCID:PMC10435520)
Rattigan, K. M. et al.
(2023)
Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cells.
EMBO Reports,
(doi: 10.15252/embr.202256279)
(PMID:37489735)
(Early Online Publication)
2021
Ianniciello, A. et al.
(2021)
ULK1 inhibition promotes oxidative stress–induced differentiation and sensitizes leukemic stem cells to targeted therapy.
Science Translational Medicine, 13(613),
eabd5016.
(doi: 10.1126/scitranslmed.abd5016)
(PMID:34586834)
Natto, M. J., Hulpia, F., Kalkman, E. R., Baillie, S., Alhejely, A., Miyamoto, Y., Eckmann, L., Van Calenbergh, S. and de Koning, H. P.
(2021)
Deazapurine nucleoside analogues for the treatment of Trichomonas vaginalis.
ACS Infectious Diseases, 7(6),
pp. 1752-1764.
(doi: 10.1021/acsinfecdis.1c00075)
(PMID:33974405)
2017
Lote, H. et al.
(2017)
Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer.
Annals of Oncology, 28(6),
pp. 1243-1249.
(doi: 10.1093/annonc/mdx074)
(PMID:28327965)
(PMCID:PMC5452067)
2013
Duffy, M. R., Parker, A. L., Kalkman, E. R., White, K., Kovalskyy, D., Kelly, S. M. and Baker, A. H.
(2013)
Identification of novel small molecule inhibitors of adenovirus gene transfer using a high throughput screening approach.
Journal of Controlled Release, 170(1),
pp. 132-140.
(doi: 10.1016/j.jconrel.2013.05.007)
2012
Duffy, M.R., Kalkman, E. and Baker, A.H.
(2012)
Identification of a novel small molecule inhibitor of FX-mediated Ad5 gene transfer for gene therapy applications.
Molecular Therapy, 20(S1),
S117-S117.
(doi: 10.1038/mt.2012.86)
This list was generated on Sun Oct 1 18:52:27 2023 BST.